Delhi’s healthcare crisis: a wake-up call ahead of elections
Ahead of Delhi Assembly elections on February 5, JSA Delhi warns about persisting health inequities and calls for meaningful health policies
India’s newly amended patent rules threaten affordable medicines in the Global South
New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South
Pandemic Treaty continues to negate principles of equity and justice
Pandemic Treaty talks face hurdles as equity concerns, corporate dominance, and calls for fair health frameworks remain unaddressed
Sí, podemos impedir que las patentes obstaculicen el tratamiento de la tuberculosis
Un día antes del Día Mundial de la Tuberculosis, la Oficina de Patentes de la India rechazó la solicitud del gigante farmacéutico Jannsen de prorrogar la patente del medicamento bedaquilina.
Yes, we can stop patents getting in the way of TB treatment
A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug
Health movement in South Korea fights for universal access to medicines
Civil society in South Korea renewed its commitment to ensure universal access to medicines and public pharmaceutical production, building on decades of mobilization
Cuban Vaccine to be produced in Italy in attempt to solve WHO prequalification hurdle
Cuba–Italy collaboration on COVID-19 moves forward as memorandum for production of vaccines is signed between Finlay Institute of Vaccines and Italian biotech company
Cuba is helping vaccinate the world
Only 9.5% of people in low-income countries have received a single dose of the vaccine. Cuba has a comprehensive plan to support vaccine distribution in the global south to make sure none are left behind